Bionik Laboratories Completes US $13.1 Million Private Placement
Toronto, ON – July 7, 2015 – Bionik Laboratories Corp. (OTCBB: BNKL), a medical device and robotics company with a core focus in robotic exoskeleton technology for users with mobility impairments (“Bionik” or the “Company”), announced today that it has Read More >>
Bionik Laboratories is an innovative medical device company developing transformational robotic rehabilitation technologies. The company focuses on reinventing and advancing the standards of biomechatronics, and developing innovative technologies that redefine rehabilitation for patients with restricted physical mobility.
The company's lead program, ARKE is a lower body, robotic exoskeleton that allows patients with mobility impairments the ability to walk. Currently in clinical development, ARKE will initially be used in a rehabilitation environment, with the goal of being made available for home use.